Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[ 18 F]FDG PET-Negative Marrow: Results From an International Retrospective Study - Federico Mercolini; Marissa Just; Barry L. Shulkin; Natalie B. Collins; Jacquelyn Crane; Douglas Harrison; Maria C. Affinita; Wendy Allen-Rhoades; Alessandra Alessi; Sebastian D. Asaftei; Michael A. Arnold; Sonja Chen; et al. (Journal of Clinical Oncology, 2026)